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Zebrafish IRF1, IRF3, and IRF7 Differentially Regulate
IFNF1 and IFNF3 Expression through Assembly of Homo-
or Heteroprotein Complexes
Hui Feng,1,2 Qi-Min Zhang,1 Yi-Bing Zhang, Zhi Li, Jun Zhang, Ya-Wei Xiong,
Min Wu, and Jian-Fang Gui
In mammals, IFN regulatory factor (IRF)1, IRF3, and IRF7 are three critical transcription factors that are pivotal for cooperative
regulation of the type I IFN response. In this study, we explored the relative contribution of zebrafish (Danio rerio) IRF1 (DrIRF1),
IRF3 (DrIRF3), and IRF7 (DrIRF7) (DrIRF1/3/7) to zebrafish IFNF1 (DrIFNF1) and IFNF3 (DrIFNF3) (DrIFNF1/3) activa-
tion. Following spring viremia of carp virus infection, DrIFNF1/3 and DrIRF1/3/7 transcripts are significantly induced in zebra-
fish tissues, which correlates with the replication of spring viremia of carp virus. DrIRF1/3/7 selectively bind to the IRF-binding
element/IFN-stimulated regulatory element sites of DrIFNF1/3 promoters, with the exception that DrIRF3 has no preference for
two IRF-binding element/IFN-stimulated regulatory element motifs within the DrIFNF3 promoter. Consistently, DrIRF3 alone
activates DrIFNF1, but not DrIFNF3; DrIRF7 predominantly stimulates DrIFNF3; and DrIRF1 has similar potential to
DrIFNF1 and DrIFNF3. Strikingly, DrIRF3 facilitates the binding of DrIRF1 and DrIRF7 to both zebrafish IFN promoters,
and so does DrIRF7 for the binding of DrIRF1, particularly to the DrIFNF3 promoter. These binding properties correlate with
differential responses of DrIFNF1 and DrIFNF3 to the combinatory stimulation of DrIRF1/3/7, depending on their relative
amounts. Similar to the dual roles of human IRF3 in regulating IRF7-activated IFNa genes, DrIRF3 exerts dual effects on
DrIRF1-mediated DrIFNF3 gene expression: an inhibitory effect at lower concentrations and a synergistic effect at higher
concentrations. These data provide evidence that fish and mammals have evolved a similar IRF-dependent regulatory mechanism
fine-tuning IFN gene activation. The Journal of Immunology, 2016, 197: 1893–1904.
I
n mammals, type I IFNs (primarily IFN-a/b) are induced to
boost the immune response, protecting hosts from viral and
nonviral pathogens (1). Transcriptional initiation of type I
IFN genes depends on timely recognition of pathogenic signals
through host pattern recognition receptors within endosomes
(such as TLR2/3/4/7/8/9) or in the cytosol (such as cytosolic RNA
sensors, RNA helicases, and cytosolic DNA sensors) (2). Such
recognition events trigger distinct signaling pathways that finally
converge on the activation of a family of transcriptional factors
called IFN regulatory factors (IRFs) (1). The IRF family includes
9 members in mammals, 10 members in birds, and 11 members in
fish (3). All IRFs contain a conserved N-terminal DNA-binding
domain (DBD) characterized by five tryptophan repeat elements.
By folding to a helix-turn-helix motif, DBD specifically recog-
nizes and binds to a similar DNA sequence termed an IRF-binding
element (IRF-E)/IFN-stimulated response element (ISRE) within
the promoters of type I IFN genes and IFN-stimulated genes
(4–7). In addition to DBD, each family member contains a unique
C-terminal IRF-associated domain that accounts for interactions
with other IRFs and transcription factors (1).
Among the IRF family, IRF1, IRF3, and IRF7 are characterized
early in regulating type I IFN expression (1). In most cell types, the
IRF3/7-dependent IFN response is activated through the cytosolic
RNA-mediated mitochondrial antiviral signaling protein path-
way and the cytosolic DNA-mediated mediator of IRF3 activator
pathway (1, 2). IRF3 and IRF7 also contribute to TLR3-dependent
IFN expression, and IRF3 is primarily responsible for TLR4-IFN
signaling through the TIR domain-containing adaptor protein
pathway (8). However, TLR2/7/8/9-mediated induction of type I
IFN appears to use distinct IRFs in a cell type–specific fashion but
through a common adaptor called MyD88 (9–12). For example,
the TLR9-triggered type I IFN response exclusively requires IRF7
in plasmacytoid dendritic cells (DCs) (9), IRF1 in conventional
DCs (cDCs) (13, 14), and IRF3 in B lymphocytes (15); IRF1 and
IRF7 are necessary for the TLR2-driven type I IFN response in
immune cells, including macrophages and cDCs (12), and for the
TLR7/9-triggered IFN response in cDCs (11). Therefore, like
IRF3 and IRF7, IRF1 is another critical regulator of the type I IFN
response (16, 17).
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Interestingly, accumulating data showed that other IRF members
also participate in retinoic acid–inducible gene I–like receptor
(RLR)-IFN or TLR-IFN signaling. IRF8 directs the IFN response,
together with IRF3/7, in DCs (18) and with IRF3 in human blood
monocytes (19). IRF3, IRF5, and IRF7 coordinately act in mye-
loid DCs downstream of mitochondrial antiviral signaling protein
signaling (20). Following Lactobacillus acidophilus infection,
MyD88 triggers IFN-b responses in DCs through a mechanism
involving IRF1, IRF3, and IRF7 (21). These results suggest that
multiple IRF members often work together to coordinately reg-
ulate type I IFN gene activation, although the molecular mecha-
nisms involved remain unclear.
Studies during the past decade have led to tremendous ad-
vances in the understanding of fish IFN responses (22–24). Despite
functional similarity, fish IFNs are classified into group I and
group II IFNs (25–27), and they signal through distinct receptors
that are different from mammalian type I IFNRs (26). Neverthe-
less, fish IRF family members exhibit an orthologous relationship
with mammalian homologs (3, 28) and play conserved roles in the
host antiviral response (28–34). Notably, IRF3 and IRF7 are
necessary for the RLR-mediated IFN response in zebrafish (Danio
rerio) (29, 32), as well as for the MyD88-mediated IFN response
in Atlantic salmon (Salmo salar) (35); zebrafish (D. rerio) IRF1
(DrIRF1) synergizes with MyD88 to regulate the expression of
zebrafish IFNF3 (DrIFNF3) (36). Furthermore, fish IRF3 is an
IFN-inducible protein and is translocated to the nucleus following
virus infection or IFN treatment (28). These unique findings
prompted us to explore the coordination of fish IRF3 with other
IRF members, such as IRF1 and IRF7, on the IFN antiviral re-
sponse.
In the current study, we determined the relative contribution
of zebrafish IRF1, IRF3, and IRF7 (DrIRF1/3/7) to distinct zebra-
fish IFN activation. RT-PCR revealed the expression of zebrafish
IFNF1 (DrIFNF1) and DrIFNF3 (DrIFNF1/3), together with
DrIRF1/3/7, in some zebrafish tissues, and coimmunoprecipitation
(co-IP) showed the interaction of DrIRF1/3/7 and MyD88, implying
that DrIRF1/3/7 might coregulate DrIFNF1 and DrIFNF3 gene
activation. Based on in vitro pull-down assays and promoter acti-
vation analyses, we found that DrIRF1/3/7 coordinately bound to
IRF-E/ISRE motifs within DrIFN promoters as homo- or hetero-
protein complexes to synergistically stimulate or downregulate the
expression of DrIFNF1 and DrIFNF3, depending on their combi-
natory binding and the relative amounts.
Materials and Methods
Cells, virus, and zebrafish
Crucian carp (Carassius auratus L.) blastula embryonic cells, epithe-
lioma papulosum cyprini cells, and zebrafish liver cells (ZFLs) were
cultured as described previously (37, 38). Spring viremia of carp virus
(SVCV) was propagated and titered in epithelioma papulosum cyprini
cells. Zebrafish (D. rerio) was maintained and infected i.p. with 50 ml of
SVCV (108 TCID50/ml)/fish, as described (36).
Plasmids
For in vitro translation and co-IP assays, the expression plasmids were
generated by inserting the open reading frames (ORFs) of DrIRF1,
zebrafish IRF3 (DrIRF3), and zebrafish IRF7 (DrIRF7) into a pCS2(+)
vector that had precloned the HA/Myc coding sequence into the XbaI
restriction site. For luciferase assays, the ORFs of DrIRF1, DrIRF3, and
DrIRF7 were cloned into the EcoRI and NotI sites of the pcDNA3.1(+)
vector. For prokaryotic expression, the ORF of DrIRF3 was cloned into
EcoRI and NotI sites of pGEX4T-1. All constructs were confirmed by
sequencing. Other plasmids, including zebrafish IFN promoter-driven
luciferase plasmids DrIFNF1pro-luc and DrIFNF3pro-luc, zebrafish
myeloid differentiation factor 88 (DrMyD88)-Flag were described pre-
viously (29, 36).
Luciferase activity assays
Stimulation, transfection, and subsequent luciferase activity assays were
performed as previously described (28, 29, 37).
DNA pull-down assays
DNA pull-down assays were performed as described previously (36, 39),
with in vitro–translated IRF proteins, prokaryotically expressed proteins, or
cell lysates of HEK293T transfected or not with IRF expression plasmids.
Zebrafish IRF proteins were in vitro–translated in the TNT SP6 Quick
Coupled Transcription/Translation System supplemented with 40 mM KCl
(Promega) or expressed as recombinant proteins by a prokaryotic expression
system, according to previous studies (27, 28), or they were overexpressed
as tag-fused proteins by transfection of HEK293T cells for 24 h. Briefly,
25 ml of individual translated products, 4 mg of recombinant products, or an
adequate amount of IRF-overexpressing HEK293T cell lysates (one fifth of
a 10 cm-dish, unless otherwise indicated), together with 1 mg of biotinylated
promoter dsDNA, was incubated in HKMG buffer at 4˚C for 24 h. The bead-
bound DNA-protein complex was captured with M-280 streptavidin-coupled
Dynabeads (Invitrogen) and washed with incubation buffer five times, fol-
lowed by further Western blotting analysis.
Quantitative RT-PCR
Tissues were sampled from healthy zebrafish or ones that had been infected
for 48 h with SVCV, and total RNA was extracted for further expression
analysis of zebrafish IRFs, zebrafish IFNs, and SVCV genes, including L, N,
and G, by quantitative RT-PCR (qRT-PCR). qRT-PCR was also used to
detect zebrafish IRF and IFN expression in ZFLs, which were seeded in six-
well plates and transfected with polyinosinic-polycytidylic acid [poly(I:C);
2 mg/ml] or treated with SVCV (1000 TCID50/ml) and recombinant crucian
carp IFN (rIFN) protein (5 ng/ml). rIFN protein was generated by a pro-
karyotic expression system (27). qRT-PCR was performed in a DNA En-
gine Chromo4 Real-Time PCR System with SYBR Green Real-Time PCR
Master Mix (both from Bio-Rad) (27). All samples were analyzed in trip-
licates, and the expression values were normalized to b-actin. The following
primer sequences were used: DrIRF1 (F: 59-CCGGCGGATGAAGGGTC-
TGT-39, R: 59-CGTTGCATGTGCTGTCAGGG-39); DrIRF3 (F: 59-CAA-
AACCGCTGTTCGTGCC-39, R: 59-CATCGTCGCTGTTGGAGTCCT-39);
DrIRF7 (F: 59-AGGCAGTTCAACGTCAGCTACCAT-39, R: 59-TTCCAC-
CAAGTTGAGCAATTCCAG-39); DrIFNF1 (universal primers F: 59-ACG-
ACAGAATCTCTGAACCT-39, R: 59-GTCAGGACTAAAAACTTCAC-39);
the secreted DrIFNF1 isoform (F: 59-TGAGAACTCAAATGTGGACCT-39,
R: 59-GTCCTCCACCTTTGACTTGT-39); the intracellular DrIFNF1 iso-
form (F: 59-ACGGCAGCCTGAAATACGTT-39, R: 59-GTCCTCCACCT-
TTGACTTGT-39); DrIFNF3 (F: 59-TTCTGCTTTGTGCAGGTTTG-39, R:
59-GGTATAGAAACGCGGTCGTC-39); SVCV N gene (F: 59-GGTGCGA-
GTAGAAGACATCCCCG-39, R: 59-GTAATTCCCATCATTGCCCCAGA-
C-39); SVCV L gene (F: 59-CAAGTTCACAATCGGGAAGACGC-39, R:
59-CCAGTTGCTTGTTGGCTTATCCG-39); and SVCV G gene (F: 59-CC-
ATTCTGTTCATTTGGAGCCGTA-39, R: 59-AATTTCATTCGACAAGA-
CCCCC-39).
Co-IP and Western blots
Co-IP assays and Western blots were performed, as previously described (28,
29, 37). The following commercial Abs were used: anti-myc, anti-HA, anti-
Flag (Cell Signaling Technology, Danvers, MA), and anti-GST (Merck
Millipore, Darmstadt, Germany). Anti-crucian carp IRF3 and IRF7 Abs were
raised by immunization of rabbit with prokaryotically expressed crucian carp
IRF3-DBD or IRF7-DBD, as described previously (28). We confirmed the
binding specificity of both fish IRF Abs to zebrafish IRF3 and IRF7.
Results
Expression patterns of DrIRF1/3/7 with DrIFNF1 and
DrIFNF3 in stimulated cells and tissues
Previous results showed that DrIRF1/3/7 upregulate the expres-
sion of DrIFNF1 and DrIFNF3 (29, 36). To further delineate the
functional link among them, we determined their expression pat-
terns in ZFLs and selected zebrafish tissues. As shown in Fig. 1,
all five molecules were constitutively transcribed in nonstimulated
ZFLs, albeit at varied expression levels; three stimuli, including
poly(I:C), SVCV, and rIFN protein, induced their expression
quickly over a 24-h time course. DrIRF1 and DrIRF7 were in-
duced continuously, displaying similar levels during early stimu-




















lation and obviously different expression values afterward (6 h
posttreatment), whereas DrIRF3 transcripts reached a peak at 12 h
posttreatment and decreased slightly thereafter (Fig. 1A). Notably,
DrIRF1 and DrIRF7 were transcriptionally expressed much more
than IRF3 in nonstimulated and stimulated cells (Fig. 1A). DrIFNF1
and DrIFNF3 were also induced under the same conditions, with
a higher constitutive expression and a more rapid induction for
DrIFNF1 (Fig. 1B).
Detection of these five transcripts in 13 tissues of healthy
zebrafish showed that DrIRF1 had the highest level of constitutive
expression among the three IRFs (Fig. 2A). DrIFNF1 has two
isoforms (40, 41). RT-PCR analysis showed that the intracellular
DrIFNF1 isoform (without a secretion peptide) was more sig-
nificantly expressed than the secreted one (with a secretion pep-
tide) in healthy tissues, and DrIFNF3 transcripts were richer than
secreted DrIFNF1. Despite the varied expression levels, IRF and
IFN molecules were generally abundant in thymus, gill, heart, and
muscle, whereas their abundance was moderate or poor in the rest
of the tissues (Fig. 2A). After SVCV infection, these molecules
were transcriptionally upregulated to different extents in all tis-
sues, predominantly liver, intestine, and skin (Fig. 2B). With
regard to the two DrIFNF1 isoforms, although the secreted one
had low basal expression in healthy tissues (Fig. 2A), it was more
strongly induced by viral infection than the intracellular one and
DrIFNF3 (Fig. 2B). Subsequent analysis of three SVCV gene
transcripts, including L, N, and G, showed relatively high ex-
pression in hypophysis, thymus, gill, liver, and muscle (Fig. 2C),
in which zebrafish IFN transcription was also induced (Fig. 2B).
These results suggested that SVCV infection induces simulta-
neous expression of DrIFNF1/3 and DrIRF1/3/7 in zebrafish cells
and tissues.
Interaction of zebrafish IRF1/3/7 with MyD88
In mammals, IRF1/7 interact with MyD88 (9, 13, 14), and so does
mammalian IRF3 (42). To determine whether DrIRF3 and
DrIRF7, like salmon homologs (35), interact with DrMyD88, we
performed co-IP assays in HEK293T cells co-overexpressing
FLAG-tagged DrMyD88 with hemagglutinin (HA)-tagged DrIRF1
(IRF1-HA), HA-tagged DrIRF3 (IRF3-HA), or HA-tagged DrIRF7
(IRF7-HA). Consistent with our previous results (36), DrIRF1 was
physically associated with DrMyD88, because the protein complex
immunoprecipitated by anti-FLAG Ab was also recognized by anti-
HA Ab (Fig. 3A, upper panels); however, an unrelated protein
(EGFP) was not under the same condition (Fig. 3A, lower panels).
Similar results were observed for transfection of DrMyD88 with
either DrIRF3 or DrIRF7 (Fig. 3B, 3C). Combined with the ex-
pression analysis of DrIFN1/3/7 and DrIFNF1/3 (Figs. 1, 2), these
results suggest that zebrafish IRF1, IRF3, and IRF7 might simulta-
neously regulate IFN gene expression in certain tissues or cell types
through similar signaling pathways, such as the MyD88 pathway.
Binding of DrIRF1/3/7 to IRF-E/ISRE motifs within promoters
of DrIFNF1/3
It is well-known that mammalian IRF-activated type I IFN ex-
pression depends on direct binding to IFN promoter regions (1). We
confirmed that DrIRF1 binds to DrIFNF1 (corresponding to the
secreted isoform hereafter, unless indicated) and DrIFNF3 pro-
moters (36). Thus, we asked whether this might be the case for
DrIRF3 and DrIRF7 as well. To this end, DNA pull-down assays
were performed by incubation of biotin-labeled promoter DNAs of
DrIFNF1 (2596 to +38) or DrIFNF3 (21455 to 21102), which
bear three or two putative ISRE/IRF-E–like motifs (36), with
in vitro–translated DrIRF1/3/7 proteins to determine whether each
of them was able to bind to IFN promoters. As shown in Fig. 4A,
in vitro translation of an HA-tagged DrIRF1 plasmid (IRF1-HA)
generated a theoretically sized protein and a large-sized one;
Western blot analysis of promoter-bound products showed that
both forms of DrIRF1 effectively bound to IFNF1/3 promoters.
Two protein forms were also observed for in vitro–translated
DrIRF7 or DrIRF3, with a main one corresponding to the expected
m.w. and a weak one that is likely to be a degraded form. Only the
theoretically sized DrIRF7 bound to IFN promoters and, unex-
pectedly, none of the in vitro–translated DrIRF3 do so under the
same conditions (Fig. 4A).
FIGURE 1. RT-PCR analysis of zebrafish IRF1, IRF3, and IRF7 together with zebrafish IFNF1 and IFNF3 in ZFLs. ZFLs seeded in six-well plates were
transfected with poly(I:C) (2 mg/ml) or treated with SVCV (1000 TCID50/ml) or recombinant IFN protein (5 ng/ml). At the indicated time points, the cells
were sampled for real-time PCR analysis of DrIRF1/3/7 (A) and DrIFNF1/3 (B) expression by different stimuli. Amplification of DrIFNF1 was conducted
by universal primers. The expression level is relative to the corresponding expression level of b-actin. Error bars represent SDs obtained by measuring each
sample in triplicate.




















To further characterize the binding nature of DrIRF3, DrIRF3
(IRF3-HA) or DrIRF7 (IRF7-HA) was overexpressed in HEK293T
cells, from which the cell lysates were used to repeat DNA pull-
down assays. Western blot detection of the transfected cell lysates
showed a theoretically sized form and at least one large-sized form of
DrIRF3 (Fig. 4B). As a positive control, overexpression of DrIRF7
resulted in an intense theoretically sized protein that bound to
DrIFNF1/3 promoters and sometimes a faint slow-migrating band
that was undetectable in the promoter-bound products. In contrast to
in vitro–translated DrIRF3, all overexpressed DrIRF3 forms bound
to both zebrafish IFN promoters (Fig. 4B). Further, a recombinant
fusion protein (GST-IRF3) was made by a prokaryotic expression
system (Fig. 4C, left panels), and, expectedly, GST-IRF3 exhibited a
strong binding affinity to DrIFN promoters (Fig. 4C, right panel).
This prokaryotic expression system simultaneously produced a
degraded form of GST-IRF3 that retained the IFN promoter binding
affinity due to the existence of N-terminal DBD (Fig. 4C). Thus,
DrIRF3 physically binds to zebrafish IFN promoters.
In subsequent assays, we constructed a set of IFN promoter
mutants lacking the individual IRF-E/ISRE motif to examine the
exact binding affinity of DrIRF1, DrIRF3, and DrIRF7 (Fig. 5).
Compared with the amounts of three IRF proteins bound to the
wild-type DrIFNF1 promoter, significantly less IRF protein was
pulled down by the DrIFNF1 promoter lacking the distant IRF-E1
motif. Deleting the proximal IRF-E3 motif caused a moderate re-
duction in the band intensities of three DrIRFs, whereas deleting the
middle IRF-E2 motif only led to a slight decrease in DrIRF3
binding (Fig. 5, upper panels). With regard to the DrIFNF3 pro-
moter, deleting the distant IRF-E1 motif led to a significant re-
duction in DrIRF7 binding, a moderate reduction in DrIRF1
binding, and a slight decrease in DrIRF3 binding. Deleting the
proximal IRF-E2 motif caused a moderate reduction in DrIRF7
binding, a slight decrease in DrIRF3 binding, and no obvious effect
on DrIRF1 binding (Fig. 5, lower panels). Collectively, these data
suggest that DrIRF1, DrIRF3, and DrIRF7 differentially bind to the
IRF-E/ISRE motifs within DrIFNF1 and DrIFNF3 promoters.
Physical binding of DrIRF1/3 to IFN promoters independently
of phosphorylation
It was possible that the slow-migrating protein of DrIRF3 in the
overexpressed HEK293T cells represented a phosphorylated form.
To address this and determine whether such phosphorylation was
essential for the binding affinity of IRF proteins to IFN promoters,
lambda protein phosphatase (lambda PPase) was used to treat
DrIRF1 and DrIRF3 before or after DNA pull-down assays. As
shown in Fig. 6, in vitro translation gave two forms of DrIRF1;
transfection of HEK293T cells with DrIRF3 plasmid generated
three migrating protein forms (i.e., one main band at the expected
FIGURE 2. RT-PCR analysis of DrIRF1/3/7 and DrIFNF1/3 in healthy or infected zebrafish. The indicated tissues were collected from wild-type
zebrafish (A) or from zebrafish injected i.p. with PBS or SVCV (5 3 106 TCID50) (B) for qRT-PCR detection of DrIFNF1/3 and DrIRF1/3/7. Universal
primers were used for analysis of total DrIFNF1, and specific primers were used for the secreted or intracellular isoforms. (C) At the same time, the
expression of SVCV genes G, L, and N was determined in virally infected tissues. The expression level is shown relative to the corresponding expression
level of b-actin (A) or as fold induction relative to that in corresponding tissues injected with PBS i.p., which was set to 1 (B and C). Error bars represent
SDs obtained by measuring each sample in triplicate.




















m.w. was accompanied by two weak, slow-migrating ones).
Incubation of lambda PPase did not affect the mobility of any
rapid-migrating protein, but it resulted in the disappearance of
the more slowly migrating form of DrIRF1 and only the most
slowly migrating one of DrIRF3. Regardless of whether lambda
PPase treatment occurred before or after incubation with IFN
promoters, DNA pull-down assays showed that neither IRF1
nor IRF3 lost their binding affinities. As control, pretreatment
of DrIRF7 with the protein phosphatase did not influence its
binding to IFN promoters. These results suggest that physical
binding of DrIRF1/3 to IFN promoters is a phosphorylation-
independent action.
FIGURE 3. Immunoprecipitation anal-
ysis of the association between zebrafish
IRF1 and MyD88. HEK293T cells, seeded
in 10-cm dishes, were cotransfected with 5mg
of FLAG-tagged DrMyD88 and 5 mg of
IRF1-HA (A), IRF3-HA (B), or IRF7-HA
(C) or empty vector pCS2+ (A–C, upper
panels) and EGFP-HA (A–C, lower panels)
as control. Twenty-four hours later, the trans-
fected cells were immunoprecipitated with
anti-FLAG Ab, followed by analysis of the
immunoprecipitates by Western blotting.
FIGURE 4. The binding affinity of zebrafish IRF1, IRF3, and IRF7 to zebrafish IFNF1 and IFNF3 promoters. (A) In vitro-translated DrIRF1 and
DrIRF7, but not DrIRF3, bind to both zebrafish IFN promoters by pull-down assays. A total of 1 mg of biotin-labeled DrIFNF1 (2596 to +38) or DrIFNF3
(21455 ∼21102) promoter DNAs was incubated with the indicated in vitro–translated DrIRF1, DrIRF3, or DrIRF7 at 10-fold amounts of input. The bead-
bound DNA-protein complex was detected by Ab specific to HA tag. (B) DrIRF3 and DrIERF7 overexpressed in HEK293T cells are capable of binding to
zebrafish IFNF1 or IFNF3 promoters by pull-down assays. HEK293T cells seeded in 10-cm dishes were transfected with 10 mg of DrIRF3 or DrIRF7 or
empty vector pCS2 as control. At 24 h posttransfection, cells were harvested for sonication in HKMG buffer. A total of 2% of DrIRF3- or DrIRF7-
containing cell lysates was loaded as input, and 45% was used for DrIFNF1 or DrIFNF3 promoter binding analysis, as described in (A). (C) Prokaryotically
expressed DrIRF3 is capable of binding to zebrafish IFNF1 or IFNF3 promoters by pull-down assays. Zebrafish GST-IRF3 was expressed by a prokaryotic
expression system and purified (left panels). A total of 4 mg of the purified GST-IRF3 protein was incubated with 1 mg of biotin-labeled DrIFNF1 or
DrIFNF3 promoter DNA, and the bead-bound DNA-protein complexes were detected by Ab specific to GST tag.




















Binding of DrIRF1/3/7 to IFN promoters as homo- or
heteroprotein complexes
To determine whether zebrafish IRF1, IRF3, and IRF7 could coop-
eratively regulate IFN responses, co-IP experiments were first per-
formed to examine their potential to form homo- or heteroprotein
complexes. Two sets of IRF constructs carrying the myc tag or the
HA tag were used to transfect HEK293T cells. In IRF1-myc–over-
expressing cells and IRF1-HA–overexpressing cells, anti-myc Ab–
immunoprecipitated protein complex was recognized by anti-HA Ab
(Fig. 7A, upper panels). However, an unrelated protein (EGFP-HA)
was not immunoprecipitated by IRF1-myc (Fig. 7A, lower panels).
These results indicated that DrIRF1 was able to form homodimers.
The same was true for DrIRF3 and DrIRF7 (Fig. 7B, 7C). In another
experiment in which HEK293T cells were cotransfected with
IRF1-HA and IRF3-myc, anti-HA Ab–immunoprecipitated protein
complex was detected by anti-IRF3 Ab (Fig. 7D, upper panels) or
anti-myc Ab–immunoprecipitated protein complex was detected by
anti-HA Ab (Fig. 7D, lower panels), suggesting that DrIRF1 was
associated with DrIRF3. Similar results showed that DrIRF1 also
interacted with DrIRF7 and so did DrIRF3 with DrIRF7 (Fig. 7E, 7F).
Considering that in vitro–translated DrIRF3 protein alone
failed to bind to IFN promoters, we wondered whether it would
do so by virtue of in vitro–translated DrIRF1 or DrIRF7. DNA
pull-down assays were performed with DrIRF1/3/7 individually
or collectively at a constant amount for each IRF protein
(Fig. 7G). Western blot analysis of DrIFNF1 or DrIFNF3 promoter-
bound IRF proteins showed that in vitro–translated DrIRF1 and
DrIRF7, but not in vitro–translated DrIRF3, were easily detected
in single IRF-included reaction setups. Unexpectedly, in vitro–
translated DrIRF3 was still undetectable in the combined reaction
setups in which DrIRF1 or DrIRF7 or both were included. Inter-
estingly, compared with the reaction setup that included only DrIRF1,
two combined reaction setups (DrIRF1+DrIRF7 or DrIRF1+
DrIRF3+DrIRF7) displayed an obviously enhanced binding of
DrIRF1, particularly to the DrIFNF3 promoter (Fig. 7G), implying
a benefit of DrIRF7 on DrIRF1 binding to fish IFN promoters.
To determine whether DrIRF3 would bind to IFN promoters
through the formation of homoprotein complexes, we set up
reconstitution reaction-based DNA pull-down assays by mixing
in vitro–translated DrIRF3 (IRF3-HA) with the lysates of
HEK293T cells transfected or not with IRF3-HA. As shown in
Fig. 7H, Western blot with anti-HA Ab failed to detect in vitro–
translated DrIRF3 in IRF3-alone–included pull-down assays;
however, the combination of the same amount of in vitro–
translated DrIRF3 and regular HEK293T cell lysates led to
detectable binding (Fig. 7H), probably because human IRF3
proteins that were expressed constitutively in HEK293T cells
helped in vitro–translated DrIRF3 bind to IFN promoters by
forming a homoprotein complex. No binding was detected in
the solely HEK293T cell lysate–included reaction because hu-
man IRF3 was not recognized by anti-HA Ab; however, a strong
binding was seen when HEK293T cells were transfected with
IRF3-HA (Fig. 7H). Further assays used a reconstituted DrIRF3
protein mixture consisting of in vitro–translated IRF3 and
HEK293T cell lysates in which free-tagged or HA-tagged DrIRF3
had been overexpressed; anti-HA Ab detection of the pull-down
proteins showed an obvious binding for the former mixture (over-
expression of free-tagged IRF3) and an enhanced binding for the
latter (overexpression of IRF3-HA) (Fig. 7I). Collectively, these
data suggested that zebrafish IRF1/3/7 bind to fish IFN promoters as
homo- and heteroprotein complexes.
FIGURE 5. The binding of zebrafish IRF1, IRF3, and IRF7 to zebrafish
IFNF1- and IFNF3-derived IRF-E/ISRE binding sites. DNA pull-down
assays were performed by incubating 1 mg of biotin-labeled mutant pro-
moter DNA, which lacked the individual IRF-E/ISRE motif of DrIFNF1
or DrIFNF3, with in vitro–translated DrIRF1, in vitro–translated DrIRF7,
and DrIRF3-overexpressing HEK293T cell lysates. The bead-bound DNA-
protein complexes were detected by Ab specific to HA tag.
FIGURE 6. Physical binding of DrIRF1 and DrIRF3 to DrIFNF1 and
DrIFNF3 promoters without phosphorylation. DNA pull-down assays
were performed as in Fig. 5. For in vitro–translated DrIRF7, the protein
was pretreated or not with lamda PPase before pull-down assays. For
in vitro–translated DrIRF1 and DrIRF3-overexpressing HEK293T cell
lysates, the indicated proteins were treated with lambda PPase before or
after incubation with DrIFNF1 or DrIFNF3 promoters or were left
treated. The bead-bound DNA-protein complexes were detected by
Western blotting. * and **, phosphorylation form of DrIRF1 and DrIRF3.




















Recruitment of DrIRF1/7 to bind to IFN promoters by DrIRF3
We further reconstituted DrIRF3-overexpressed HEK293T cell ly-
sates together with in vitro–translated DrIRF7 and/or DrIRF1 proteins
to perform DNA pull-down assays. As shown in Fig. 8, each fish IRF
protein could bind to zebrafish IFN promoters, with a strong binding
for the overexpressed DrIRF3 and a weak one for DrIRF1 or DrIRF7
alone. In comparison with the relatively weak binding by DrIRF1 or
DrIRF7 alone, significantly enhanced binding of DrIRF1 or DrIRF7
was observed for the reconstituted fish IRF protein mixtures that
were made up of overexpressed DrIRF3 plus DrIRF7, DrIRF1, or
both (Fig. 8). Interestingly, this effect was not reciprocal, because this
supplementation resulted in an obvious reduction, not an increase, in
DrIRF3 binding. Notably, all reactions contained equal amounts of
the same DrIRF proteins and DrIFN promoter DNAs; however, the
amounts of IRF proteins that were pulled down by IFN promoter
DNAs varied among different experiment combinations, and the
amounts of promoter DNA-bound multiple IRF proteins in a given
reconstituted reaction setup are not equal to the sum of those from
single component–included reaction. Therefore, DrIRF3 might fa-
cilitate the binding of DrIRF1 and/or DrIRF7 to fish IFN promoters.
Differential response of DrIFNF1/3 promoters to DrIRF/3/7
individually and collectively
Luciferase assays were used to determine the expression regu-
lation of DrIFNF1 and DrIFNF3 by DrIRF1, DrIRF3, and
FIGURE 7. The binding of zebrafish IRF1, IRF3, and DrIRF7 to zebrafish IFN promoters through the assembly of homo- or heteroprotein complexes.
(A–F) Immunoprecipitation analysis of the association among zebrafish IRF1, IRF3, and IRF7. HEK293T cells seeded in 10-cm dishes were cotransfected
with IRF1-myc and IRF1-HA (A), IRF3-myc and IRF3-HA (B), IRF7-myc and IRF7-HA (C), IRF1-HA and IRF3 (D), IRF1-HA and IRF7 (E), or IRF3 and
IRF7-HA (F), each with 5 mg (upper panels). Cells were transfected with the indicated IRF expression plasmids and an unrelated vector EGFP-HA as
control (lower panels). Twenty-four hours later, the transfected cells were immunoprecipitated with anti-myc Ab (A–C) or anti-HA Ab (D–F), followed by
Western blotting with the indicated Abs. Arrows indicate nonspecific binding. (G–I). Cooperative binding of zebrafish IRF1, IRF3, and IRF7 to zebrafish
IFN promoters. DNA pull-down assays were performed as in Fig. 4, by incubation of DrIFNF1 and DrIFNF3 promoter DNA with in vitro–translated
DrIRF3, in vitro–translated DrIRF1, and in vitro–translated DrIRF7, individually and collectively (G), or with in vitro–translated DrIRF3 and regular
HEK293T cell lysates, individually and collectively, and DrIRF3-transfected HEK293T cell lysates alone as control (H), or with in vitro–translated DrIRF3
and free-tagged DrIRF3-transfected HEK293T cell lysates collectively and HA-tagged DrIRF3-transfected HEK293T cell lysates as control (I). A constant
amount of in vitro–translated DrIRF3 was included, and the bead-bound DNA-protein complexes were detected by Ab specific to HA tag.




















DrIRF7. Consistent with our previous results (29, 36), over-
expression of each fish IRF resulted in activation of the DrIFNF1
promoter in a dose-dependent fashion (Fig. 9A). Similar acti-
vation of the DrIFNF3 promoter was seen in response to DrIRF1
or DrIRF7; however, DrIRF3 failed to activate the DrIFNF3
promoter (Fig. 9C). Among the three IRFs, the best stimulator of
the DrIFNF1 promoter was DrIRF3, followed by DrIRF1 and
then DrIRF7. For instance, a 19-fold increase in DrIFNF1 pro-
moter–driven luciferase activities was detected when 200 ng of
DrIRF1 was used, whereas a 160-fold increase was seen with
200 ng of DrIRF3 (Fig. 9A, top panel). In another experiment, a
35-fold increase was observed with DrIRF1 compared with a
18-fold increase with DrIRF7 (Fig. 9A, middle panel). However,
the DrIFNF3 promoter did not show such a preference for
DrIRF1 and DrIRF7 (Fig. 9C, middle panel).
Considering the varied expression levels of three zebrafish IRF
genes in stimulated cells and tissues (Figs. 1, 2), different ratios
of any two IRFs were used to evaluate the possible synergistic
effects of IRF expression levels on regulating zebrafish IFN
expression. The results showed that IFN promoter activities
obtained with two IRFs were often higher than those obtained
with one (Fig. 9A, 9C). For example, compared with transfection
of DrIRF1 alone (200 ng), cotransfection of DrIRF1 (200 ng)
and increasing amounts (10, 50, 200 ng) of DrIRF3 resulted in a
significant and continuous increase in DrIFNF1 promoter ac-
tivities (1.5-, 3.2-, and 5.5-fold higher than control, respec-
tively); when compared with transfection of DrIRF3 alone at the
corresponding amounts (10, 50, 200 ng), DrIFNF1 promoter
activities were quantified as 5.5-, 1.7-, and 1.2-fold, respectively
(Fig. 9A, top panel).
To exclude the interference of additional effects, the coopera-
tivity values were also calculated as the ratio of luciferase activity
values obtained in the presence of two IRFs/sum of luciferase
activity values obtained with each alone (Fig. 9B, 9D). We set the
criteria that values around or equal to 1 indicated no cooperative
effect, values , 1 indicated an inhibitory effect, and values . 1
indicated a synergistic activation. Using this method to reassess
the activation of the DrIFNF1 promoter by DrIRF1 plus DrIRF3,
a gradually increasing synergy was observed along with the in-
crease in the relative amounts of DrIRF3, with 1.5–2.2-fold higher
level of luciferase activities at DrIRF1/DrIRF3 ratios of 1:4–1:20
(Fig. 9B, top panel).
Interestingly, although DrIRF3 alone could not stimulate the
DrIFNF3 promoter, cotransfection of low amounts of DrIRF3 (10
and 50 ng) and 200 ng of DrIRF1 (DrIRF1/DrIRF3 ratio . 1:1)
resulted in significantly decreased luciferase activities relative to
transfection of 200 ng of DrIRF1 alone; conversely, significantly
increased luciferase activities were observed when the DrIRF1/
DrIRF3 ratio was #1:1 (Fig. 9C, top panel). These results indi-
cated a dual effect of DrIRF3 on DrIRF1-mediated DrIFNF3
expression: a synergistic induction (.1.3–3-fold higher than
control) at high DrIRF3 concentrations (DrIRF1/DrIRF3 ratio of
1:4 or 1:20) and an inhibitory effect (4–5-fold lower than control)
at low DrIRF3 concentrations (DrIRF1/DrIRF3 ratio of 20:1 or
4:1) (Fig. 9D, top panel). No obvious effect of DrIRF1/7 on
DrIFNF1 promoter activation was observed when the DrIRF1/7
FIGURE 8. Enhanced binding of zebrafish IRF1 and
IRF7 to zebrafish IFN promoters by zebrafish IRF3. DNA
pull-down assays were performed with the indicated pro-
teins as in Fig. 4. A total of 1 mg of biotin-labeled pro-
moter DNA of DrIFNF1 or DrIFNF3 was incubated with
in vitro–translated DrIRF1, in vitro–translated IRF7-HA–
and IRF3-HA–transfected HEK293T cell lysates, indi-
vidually or collectively. Each IRF was included at a constant
amount, and the bead-bound DNA-protein complexes were
detected by anti-HA tag Ab.




















ratio was #1:1 because the cooperative value was close to 1, but a
slight synergistic induction was detected at higher amounts of
DrIRF7 (.1.3-fold higher than control) (Fig. 9A, 9B, middle
panels). Similar analyses indicated an obvious synergism on
DrIFNF3 at DrIRF1/DrIRF7 ratios of 4:1–1:4, with the highest
level (nearly 4-fold higher than control) at a 1:1 ratio (Fig. 9C, 9D,
middle panels). DrIRF3 and DrIRF7 displayed robust synergism on
stimulating the DrIFNF1 promoter with increasing the relative
amounts of DrIRF7 (1.8–3-fold higher than control at DrIRF3/
DrIRF7 ratios of 1:1–1:20) (Fig. 9A, 9B, bottom panels) and dis-
play modest synergism on the DrIFNF3 promoter (up to 1.8-fold
higher than control) only at low DrIRF3/DrIRF7 ratios (1:4 and
1:20) (Fig. 9C, 9D, bottom panels).
Discussion
In mammals, accumulating data suggested that the type I IFN
response is contingent on many issues, including intracellular
locations of pathogen, sensing receptors, and IRF members; these
issues create a functional link directing a specific signaling
pathway in a given cell type (1, 2). Generally, such a link triggers
an IRF3/7-dependent IFN response from cytosolic location in
most cell types (8), an IRF7-dependent pathway, and/or an IRF1-
dependent pathway from endosomes of plasmacytoid DCs, cDCs,
or other immune cells (9, 11–14). In other instances, invading
pathogens trigger multiple signaling pathways to activate an IFN
response, such as a Listeria monocytogenes mutant that is pri-
marily recognized in phagosomes and also in the cytosol of cDCs,
thus stimulating IFNb dependently of IRF1 in phagosomes and
IRF3/7 in cytosol (11), and L. acidophilus, which upregulates
IFN-b in mouse DCs involving IRF1, IRF3, and IRF7 through the
MyD88 pathway (21). Therefore, IRF1, IRF3, and IRF7 are three
crucial transcription factors and might be simultaneously assem-
bled to IFN gene promoters, ensuring full release of IFN response.
Like mammalian IRF1, DrIRF1 is constitutively expressed in
various tissues and is inducible by IFN and IFN stimuli (Fig. 2).
Unlike mammalian IRF3 that is not inducible by IFN stimulation
and viral infection (43), and mammalian IRF7, whose expression
is limited in lymphoid cell types but is highly induced in various
cell types (1), DrIRF3 and DrIRF7 are transcriptionally expressed
in all normal tissues tested and significantly induced by SVCV
infection (Fig. 2). This disparate property of DrIRF3 and DrIRF7
is also seen in other fish species (28, 44–47), implying the pos-
FIGURE 9. Differential effects of zebrafish IRF1, IRF3, and IRF7 on zebrafish IFN promoter activation. (A) Differential response of DrIFNF1 promoter
to DrIRF1, DrIRF3, and DrIRF7 by luciferase assays. Crucian carp (C. auratus L.) blastula embryonic cells seeded in 24-well plates were cotransfected
with DrIFNF1 promoter–driven luciferase plasmid (0.25 mg) in the presence of two zebrafish IRF plasmids at the indicated amounts; 0.025 mg pRL-TK
was introduced as an internal control. At 48 h posttransfection, cells were harvested for detection of luciferase activity. The data shown are representative of
three independent experiments, each performed in triplicate. (B) Cooperativity analysis of zebrafish IRF1/3/7-mediated DrIFNF1 activation based on more
than three independent luciferase assays, as in (A). Cooperativity values between any two of zebrafish IRF1/3/7 on DrIFNF1 promoter activation were
calculated as the ratio of luciferase activities obtained in the presence of both IRF proteins/sum of luciferase activities obtained when each factor was
expressed. The values around or equal to 1 indicated no cooperative effects, values, 1 indicated an inhibitory effect, and values. 1 indicated a synergistic
activation. (C) Differential response of DrIFNF3 promoter to DrIRF1, DrIRF3, and DrIRF7 by luciferase assays. Luciferase assays were performed, as in
(A), using a DrIFNF3 promoter-driven luciferase plasmid instead of a DrIFNF1 promoter–driven luciferase plasmid. (D) Cooperativity analysis of
zebrafish IRF1/3/7-mediated DrIFNF3 activation, based on more than three independent luciferase assays, as in (C).




















sibility that fish IRF3 and IRF7 are required for IFN responses in
various cell types. Interestingly, very weak transcription of two
zebrafish IFN genes, DrIFNF1 and DrIFNF3, is detected in
healthy zebrafish tissues in which DrIRF1/3/7 are also constitu-
tively abundant (Fig. 2A). Following SVCV infection, DrIFNF1/3
and DrIRF1/3/7 are significantly induced in another set of zebra-
fish tissues (Fig. 2B), which correlates with the replication of
SVCV (Fig. 2C). SVCV is a negative ssRNA virus (48, 49). Al-
though it is uncertain how SVCV infection is recognized in fish
cells, the fact that these fish molecules highly respond to SVCV in
some common tissues prompted us to hypothesize that DrIRF1/3/7,
like their homologs in mammals (11, 21), might cooperatively
regulate zebrafish IFN gene expression on unknown occasions. In
support of this hypothesis, each of DrIRF1/3/7 interacts with
MyD88 (Fig. 3); DrIRF1, together with MyD88, upregulates
DrIFNF3 (36), and in Atlantic salmon, IRF3 or IRF7 synergizes
with MyD88 to activate the salmon IFN response (35). Notably,
zebrafish IFNF1 has two isoforms (40, 41). In the current study,
the secreted isoform of DrIFNF1 is induced more significantly
than the intracellular one by SVCV infection (Fig. 2B). The dif-
ferential induction of both DrIFNF1 isoforms is likely ascribed to
their promoter composition. The secreted DrIFNF1 isoform pro-
moter has three IRF-E motifs (IRF-E1, IRF-E2, and IRF-E3 in
Fig. 5), and the intracellular isoform promoter has only the distant
IRF-E1. Our previous results showed that the proximal IRF-E
motif primarily contributes to induction of fish IFN gene expres-
sion (28), supporting the idea that the secreted one is highly in-
ducible by SVCV. Therefore, the secreted DrIFNF1 isoform
promoter was used in the subsequent assays.
The data in the current study indicate that DrIRF1, DrIRF3, and
DrIRF7 differentially regulate zebrafish IFN expression, likely
through assembly of homo- and heteroprotein complexes binding
to IRF-E/ISRE sites in IFN promoters. First, DrIRF1, DrIRF3, and
DrIRF7 possess highly conserved N-terminal DBD (36), guaran-
teeing their binding to the IFN promoter. Second, like human
IFNa gene promoters whose IRF-E motifs are selectively recog-
nized by IRF3 and IRF7 (6, 7), each fish IRF protein binds to
cognate IRF-E/ISRE motifs of the DrIFNF1 and DrIFNF3 pro-
moters (Fig. 5). Actually, the IRF-E/ISRE motifs are directly re-
sponsible for either binding or activation of crucian carp IRF3 and
zebrafish IRF1 to fish IFN promoters (28, 36). Third, DrIRF1,
DrIRF3, and DrIRF7 are associated with one another in vitro
(Fig. 7A–F), and they bind to zebrafish IFN promoters through
the formation of homo- and heteroprotein complexes (Figs. 7G,
7H, 8). Finally and importantly, overexpression of DrIRF1,
DrIRF3, and DrIRF7 individually and collectively differentially
activates two fish promoters depending on their combination and
the relative amounts (Fig. 9).
Although eukaryotically expressed DrIRF3 in HEK293T cells
or prokaryotically expressed DrIRF3 binds to both zebrafish IFN
promoters by pull-down assays, the binding is not detectable with
in vitro–translated DrIRF3 protein alone (Fig. 4A). Interestingly,
the same phenomenon is seen for in vitro–translated human IRF3
by EMSA assays, and binding to the IFN-b promoter is observed
with a high concentration of recombinant human IRF3 in baculovirus-
infected cells (4). However, the failure to bind the IFN promoter is
not a result of fish IRF3 protein concentration, because a lower
concentration of prokaryotically expressed DrIRF3 than in vitro–
translated IRF3 used in our experiments still binds to fish IFN
promoters (data not shown). The exact causes of such a phe-
nomenon are unknown, but it is possible that a misfolded protein
conformation in in vitro–translated IRF3 restricts its binding to
IFN promoters. Notably, in vivo assays showed that, in mammals,
IRF3 binding to target gene promoters requires the activation of
two coactivators, b-catenin and CBP, by HDAC6 and PKC-b (50).
Therefore, it is important to analyze in vivo binding of fish IRF3 to
IFN promoters in the future.
The binding features of DrIRF1, DrIRF3, and DrIRF7 seem to
determine the differential response of both fish IFN gene pro-
moters. For example, DrIRF3 alone activates the DrIFNF1, but not
the DrIFNF3, promoter, whereas DrIRF1 and DrIRF7 activate
both; they differ in that DrIRF1 has no preference, and DrIRF7
prefers to activate the DrIFNF3 promoter (Fig. 9). Consistently,
pull-down assays reveal an unusual binding feature of DrIRF3: it
does not have a preference for either of the IRF-E/ISRE motifs
within the DrIFNF3 promoters, which is very different from
DrIRF3 binding to the DrIFNF1 promoter and DrIRF1/7 binding
to DrIFNF1/3 promoters, where a preferred motif is selected
(Fig. 5). In mammals, IRF3 possesses a restricted recognizing
DNA sequence, but IRF7 has a broader one (51); this selective
binding contributes to differential regulation of early-phase IFN
genes, including IFNb, and later-phase IFN genes, including most
IFNas: the former is primarily controlled by IRF3, and the latter
are controlled by IRF7 (6–8, 51–53). Considering that the IRF3/7-
dependent IFN response is activated from cytosolic locations in
most cell types (8), the similar binding and regulatory properties
of DrIRF3 and DrIRF7 support our previous notion that RLR
pathway–triggered DrIFNF1 expression is primarily regulated by
DrIRF3, thereby resembling mammalian IFNb, and DrIFNF3 is
primarily regulated by DrIRF7, thereby resembling mammalian
IFNas (29). The binding property of DrIRF1 also correlates with
its regulatory potential to activate DrIFNF1 and DrIFNF3 (36).
Interestingly, the magnitude of zebrafish IFN gene expression is
dependent on the combinatory binding of DrIRF1/3/7, as well as their
relative amounts. In the current study, the cooperativity values were
determined as the ratio of luciferase activity values obtained in the
presence of both IRFs/the sum of luciferase activity values obtained
with each alone, and the values. 1 indicate a synergistic activation
(Fig. 9B, 9D). Based on this criterion, overexpression of DrIRF1 and
DrIRF7 together results in a significantly synergistic activation of
the DrIFNF3 promoter and less activation of DrIFNF1 promoter,
but at higher amounts of DrIRF7 (Fig. 9, middle panels). This result
is consistent with the binding assays showing that DrIRF7 facili-
tates an enhanced IFN promoter binding of DrIRF1, particularly to
the DrIFNF3 promoter (Fig. 7G). The same is true for cooperative
activation of both IFN promoters by DrIRF3 together with DrIRF1
or DrIRF7, which correlates with enhanced promoter binding of
DrIRF1 and DrIRF7 as a consequence of DrIRF3 recruitment (Fig. 8).
These results indicate a molecular mechanism underlying IRF
combination-mediated differential activation of fish IFN pro-
moters. Generally, the best cooperation occurs when DrIRF3 or
DrIRF7 is present at higher amounts, likely due to the fact that
IRF3 and IRF7 are two essential transcription factors for distinct
IFN expression in most cell types (8, 29), with the exception that
DrIRF1/7-dependent DrIFNF3 expression is most significantly
induced at equal amounts of DrIRF1 and DrIRF7. The IRF
concentration-dependent IFN gene-expression patterns might re-
flect an important physiological significance. In healthy or in-
fected zebrafish tissues, DrIRF1/3/7 display various constitutive
or inducible expression levels; therefore, when these factors are
activated simultaneously in a given cell type, even downstream of
different pattern recognition receptor–mediated signaling, they
might work together to fine-tune the activation of DrIFNF1 and
DrIFNF3 genes, depending on their relative expression levels.
Although DrIRF3 alone does not activate the DrIFNF3 pro-
moter, it still regulates DrIRF1- or DrIRF7-mediated DrIFNF3
gene expression. Strikingly, DrIRF3 facilitates DrIRF7-mediated
DrIFNF3 activation only at high concentrations (Fig. 9C, 9D,




















bottom panels), and it exerts dual effects on DrIRF1-mediated
DrIFNF3 gene expression at different concentrations (Fig. 9C,
9D, top panels). When DrIRF3 is present at lower amounts than
DrIRF1, DrIRF3 significantly downregulates DrIRF1-mediated
DrIFNF3 expression; however, when DrIRF3 is expressed at
higher amounts, both transcriptional factors synergistically ac-
tivate DrIFNF3 gene expression. Similar results are observed
in mammals. Human IRF3 selectively binds to distinct IRF-E
motifs within IFNa and IFNb gene promoters (51); however,
this factor activates the expression of early-phase IFN genes like
IFNb but has no effect on most IFNa gene expression (6, 7, 51).
Similar to DrIRF3, human IRF3 selectively exerts a similarly
dual effect on IRF7-mediated IFNa gene expression (7) and an
inhibitory effect on IRF1-mediated IFNa4 gene expression (5).
Obviously, the mechanism of IRF-mediated IFN expression in
humans is not identical to that in zebrafish, and we cannot ex-
clude the possibility that there are dual effects of zebrafish IRF3
on IRF7-mediated IFN responses, because two other zebrafish
IFN genes (DrIFNF2/4) are not included in the current study.
Despite these differences, these findings suggest that zebrafish
IFN genes are regulated in a way similar to mammalian type I
IFNs. It is well known that fish IFN genes and mammalian type I
IFN genes have evolved independently, indicating that extant
fish IFN genes do not display a one-to-one orthologous rela-
tionship with mammalian IFNa/b genes (22, 25). On the con-
trary, IRF family genes seem to pre-exist in the common ancestor
of both fish and mammals, displaying a clearly orthologous
relationship between fish and mammals (3, 28, 45, 54). Based
on these findings, it is likely that fish and mammals might adopt
the pre-existing transcription factors IRF1/3/7 independently to
develop a similar regulatory mechanism, whereby the IFN re-
sponse is intricately and adequately modulated depending on
the fluctuating expression levels of IRF1/3/7 in a given tissue or
cell type.
In mammals, IRF3 phosphorylation leads to its homo or het-
erodimerization, nuclear translocation, and association withb-catenin
and CBP/p300, and this is the transcriptional complex for IFNb
expression (4, 7, 51, 55). Consistently, fish IRF3 and IRF7 lo-
calize in cytoplasm of unstimulated cells (28, 44, 56), and undergo
a cytoplasmic-to-nuclear translocation following poly(I:C) treat-
ment or virus infection, likely through phosphorylation (28, 56).
In the current study, physical binding of DrIRF3 and DrIRF1
to IFN promoters is independent of phosphorylation (Fig. 6).
Therefore, it is likely that in vivo phosphorylation activation is
required for translocation of IRF3 and IRF7 across the nuclear
membranes into the nucleus but not for physical binding to the
IFN promoters. Unlike IRF3 and IRF7, fish and mammalian
IRF1s reside in the nucleus (31, 36). Although phosphorylation of
DrIRF1 is observed, its physiological relevance remains to be
determined. Interestingly, a recent study showed that phosphory-
lation of human IRF1 in primary CD4+ T cells blocks induction of
IFN-b following treatment with poly(I:C) (57).
Collectively, the data from the present study suggest that there
is similar IRF1/3/7-regulated IFN activation between fish and
mammals. Like human IRF3 (5, 7), DrIRF3 functions as a positive
regulator and as a negative regulator of different IFN genes,
depending on different amounts of DrIRF1/3/7. These results in-
dicate a similar regulatory mechanism of IRF-mediated IFN re-
sponses in fish and mammals. In contrast with mammalian IFNa/b
(8, 52, 53), DrIFNF1 and DrIFNF3 appear not to be induced as
early- or late-phase IFNs (29), and fish IRF3 is an IFN-inducible
transcription factor and lacks an inhibitory domain (28). Therefore,
even if fish IRF1/3/7 function as partners to coordinately regulate
distinct fish IFN activation, ensuring an efficient, but not excessive,
IFN response, there might be unique fish IRF-mediated IFN regu-
lation awaiting further investigation.
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